Rapporto sull’analisi delle quote e delle dimensioni del mercato dei vaccini antinfluenzali | Previsioni 2031

  • Report Code : TIPRE00004070
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 209
Buy Now

Il mercato dei vaccini antinfluenzali è stato valutato a 7.478,53 milioni di dollari nel 2021 e si prevede che cresca  12.272,49 milioni di dollari entro il 2028; con un CAGR del 7,4% dal 2022 al 2028

L'influenza è un'infezione respiratoria contagiosa causata dal virus dell'influenza. L'influenza si manifesta con febbre, tosse, dolori muscolari e articolari, mal di testa e grave debolezza. Le malattie dovute all'influenza variano da lievi a gravi e talvolta portano alla morte. Secondo l’Organizzazione Mondiale della Sanità (OMS), nel 2018, i ricoveri ospedalieri correlati ai casi di influenza variano da 3 a 5 milioni di casi per malattie gravi, mentre i decessi correlati all’influenza vanno da circa 290.000 a 650.000. I vaccini sono consigliati per la prevenzione delle infezioni influenzali. La rapida diffusione delle epidemie di virus influenzali in tutto il mondo spinge alla richiesta di sviluppare un vaccino antinfluenzale efficace. Una solida pipeline di prodotti è un fattore chiave che guida la crescita del mercato durante il periodo di previsione.

Il mercato dei vaccini antinfluenzali viene analizzato sulla base del tipo di vaccino, tipo di virus, tecnologia, via di somministrazione, gruppo target, e geografia. In base alla geografia, il mercato è ampiamente segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e Sud & America Centrale. Il rapporto sul mercato dei vaccini antinfluenzali offre approfondimenti e analisi approfondite del mercato, sottolineando le tendenze del mercato, i progressi tecnologici, le dinamiche di mercato e l'analisi competitiva dei principali attori del mercato.

Approfondimenti strategici

< h3>Regioni redditizie per il mercato dei vaccini antinfluenzali

Approfondimenti di mercato

Aumento degli investimenti da parte dei principali attori del mercato e dei governi per guidare il mercato dei vaccini antinfluenzali

Gli operatori del mercato e i governi di tutto il mondo stanno aumentando i loro investimenti nello sviluppo di vaccini e nell’immunizzazione. Ad esempio, nel marzo 2021, Sanofi ha annunciato investimenti di circa 925 milioni di dollari in un nuovo impianto di produzione di vaccini nel suo sito preesistente a Toronto e in Canada. Gli investimenti nella nuova struttura forniranno ulteriore antigene e capacità di riempimento per i vaccini antinfluenzali quadrivalenti ad alte dosi FLUZONE di Sanofi, aumentandone la disponibilità in Canada, Stati Uniti ed Europa negli anni a venire.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment by vaccine type led the influenza vaccines market?

The quadrivalent segment held the larger share of the market in the global influenza vaccines market contributing a market share of 88.36% in 2022.

Which region is projected to be the fastest-growing region in the global influenza vaccines market?

The Asia Pacific is expected to be the fastest-growing region in the influenza vaccines market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and influenza cases in these regions will show promising growth in the influenza vaccines market.

What is the estimated influenza vaccines market size in 2021?

The influenza vaccines market is estimated to be valued at US$ 7,478.53 million in 2021.

What are the growth estimates for the influenza vaccines market till 2028?

The influenza vaccines market is expected to be valued at US$ 12,272.49 million in 2028.

What is the market CAGR value of the influenza vaccines market during the forecast period?

The CAGR value of the influenza vaccines market during the forecasted period of 2022-2028 is 7.4%.

Who are the major players in the influenza vaccines market across the globe?

The influenza vaccines market majorly consists of the players, such as Moderna, Inc.; SEQIRUS; Sanofi; GlasoSmithKline plc; Hualan Biological Engineering Inc.; Emergent Biosolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; Mylan N. V.; and AstraZeneca

What are the driving factors for the global influenza vaccines market across the world?

The factors that are driving the growth of the influenza vaccines market are increase in government support to promote influenza vaccination and increasing investment by top market players and governments.

What are influenza vaccines?

Influenza virus causes flu which is a contagious respiratory illness that infects nose, throat and lungs. It can mild or severe and sometimes may lead to death. Flu vaccination every year can help in preventing flu. However, this can be deadly, especially in high-risk groups. Aged population, pregnant women and people with one or more chronic disease or with weak immune systems are at high risk. Influenza vaccines/flu shots protect against the four influenza viruses’ subtypes that are most common. Most of the influenza vaccines are “flu shots” given with a needle, usually in the arm, but nasal spray flu vaccine are also available.

The List of Companies - Influenza Vaccines Market

  1. Moderna, Inc.
  2. SEQIRUS
  3. Sanofi
  4. GlaxoSmithKline plc.
  5. Hualan Biological Engineering Inc.
  6. Emergent BioSolutions Inc.
  7. Mitsubishi Chemical Group Corporation
  8. Serum Institute of India Pvt. Ltd
  9. MYLAN N.V.
  10. AstraZeneca

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports